Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies

The Long Run with Luke Timmerman - A podcast by Timmerman Report

Catherine Stehman-Breen, CEO of Boston-based Chroma Medicine, on developing epigenetic editing therapies.